← FDA Drug Approvals (Drugs@FDA)

FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2026-07-27

Drug application

FDA Application #

ANDA213087

Application type

Abbreviated New Drug Application (Generic)

Brand name

FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE

Generic name

FLUTICASONE PROPIONATE AND SALMETEROL

Active ingredients

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Dosage form

POWDER

Route

INHALATION

Marketing status

Prescription

Sponsor

CIPLA

Manufacturer

Cipla USA Inc.

First approval

2026-07-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown